INTRODUCTION
Glycosphingolipids in mammalian tissues are catabolized by the sequential release of monosaccharide units by specific lysosomal acid glycohydrolases [1] . It has been well documented that the catabolism of some of the glycosphingolipids by specific glycohydrolases requires the presence of activator proteins [2, 3] . There are four classes of these protein cofactors: the first activates the enzymes for the hydrolyses of GalCer-SO4 [4] , GM 1 [5] , GbOse3Cer [6] [7] [8] and several other glycolipids [9] ; the second stimulates the hydrolyses of GlcCer [10] [11] [12] [13] and GalCer [14] ; the third is the activator for the hydrolysis of sphingomyelin [15, 16] ; and the fourth is GM2 activator which activates ,-hexosaminidase A to hydrolyse GM2 [17] [18] [19] [20] [21] .
The mechanism of action of GM2 activator is not well understood, although it has been postulated that the activator extracts a single GM2 molecule from the micelles and presents it to,-hexosaminidase A [22, 23] . The physiological importance of GM2 activator has been demonstrated by the fact that the biochemical lesion of Type AB GM2 gangliosidosis is caused by a deficiency of this activator protein [18, 24, 25] . In order to perform expression studies to examine the mechanism of action of GM2 activator, we isolated a cDNA clone encoding GM2 activator. During the course of this work, a partial sequence of a GM2 activator cDNA (pGAPI) isolated from a human fibroblast library was reported [26] . Interestingly, the pGM2A cDNA we isolated from a human placenta library differed in some aspects from the fibroblast pGAPI. In this report, we present evidence for the presence of multiple GM2 activator mRNAs.
MATERIALS AND METHODS

Materials
Restriction endonucleases, T4 polynucleotide kinase and T4 DNA ligase were purchased from Promega (Madison, WI, U.S.A.) and BRL (Grand Island, NY, U.S.A.). Human placenta AgtlI libraries were the generous gifts of Dr. B. Knoll (University of Texas Medical Center, Houston, TX, U.S.A.) and Dr. J. Millan (La Jolla Cancer Research Foundation, La Jolla, CA, U.S.A.). A chicken 3-actin probe was obtained from Dr. L. Levy (Tulane Medical School). GM2 activator was isolated from human kidney according to the method described for the isolation of the activator from human liver [21] . Polyclonal antibodies against GM2 activator were raised in rabbits as reported previously [25] and purified by a protein A column.
Peptide sequence of GM2 activator
An equal volume of 6 M-guanidium chloride in 0.1 M-Nmethylmorpholine/acetic acid buffer, pH 8.3, containing 1 mM-EDTA and 2.3 mg of DL-dithiothreitol were added to 0.2 ml (25,ug) of the activator solution. After a 2 h incubation at 37°C under N2, 10,l t of 4-vinylpyridine was added. The reaction proceeded for 30 min and was then quenched by the addition of 10umol of cysteine in 50,1u of the same buffer solution. The reduced and S-pyridinylated protein was isolated by Bio-Rad P-10 gel chromatography using 500% formic acid as the eluent.
The modified protein was then freeze-dried, resuspended in 50,ul of 0.1 M-ammonium bicarbonate and treated with 0.25,g (in 2.4,u of water) of TPCK-treated trypsin twice at 37°C at 2 h intervals. The tryptic fragments were then separated using a Hewlett-Packard HP-1090 h.p.l.c. system: the digest was freezedried, redissolved in 1 % trifluoroacetic acid, applied to a Vydac protein C4 column (214TP54, particle size 5,um, 0.46 cm x 25 cm) and eluted with an acetonitrile gradient (solvent A = 0.1 % trifluoroacetic acid in water, solvent B = 0.1 0% trifluoroacetic acid in 700% acetonitrile) at a flow rate of 0.5 ml/min. The percentage of solvent B was programmed as follows: 5 min, 13%; 50min, 550%; 65 and 70min, 100 %; 75min, 13%. The tryptic peptides were sequenced on a gas-phase protein sequencer (Applied Biosystems model 470A) with an on-line phenylthiohydantoin analyser (model 120A) using a standard version 3.0 program.
Isolation of cDNA clones
A human placenta Agtl 1 cDNA library (B. Knoll) was screened as described [27] using purified polyclonal anti-(GM2 activator) antibodies. Positive clones were detected using alkaline phosphatase-conjugated polyclonal goat anti-rabbit IgG as a second antibody, followed by colour development with 5-bromo-4-chloroindol-3-yl phosphate and Nitro Blue Tetrazolium [28] . Additional clones were obtained from a second human placenta Agtl 1 library (J. Millan) using the pGM2A cDNA identified with the antibody (Fig. 1) . The (Table 1 ) from proline to methionine, was synthesized on the basis of codon usage frequencies [35] .
RESULTS
Isolation of a human GM2 activator cDNA
Approximately 106 plaques of a placenta Agtl 1 library were screened with the purified polyclonal anti-(GM2 activator) antibodies. The ten plaques which gave signals were purified and analysed by Southern blotting using a 32P-labelled 60-base probe derived from amino acid sequence data. Only one clone hybridized with the 60-mer. It did not cross-hybridize with the other nine clones. The positive clone was designated as pGM2A ( Fig.  1 ) and will be discussed in further detail below. Additional screening of the library using GM2A as a probe did not give any positive signals. A second placenta Agtl 1 library was therefore screened with the same probe. Two clones, pGAP2 and pGAP3, of 894 and 1037 bp in size respectively, were identified from the second library.
The nucleotide sequences of pGAP2 and pGAP3 are overlapping: pGAP2 extends farther 5' and pGAP3 extends farther 3'. The sequence of the two clones taken together (GAP) yields a size of 1093 bp (Fig. 2) . GAP nucleotides 64-884 correspond to the human fibroblast pGAPI cDNA which has been previously reported [26] . The N-terminal fragment and tryptic fragments [1] [2] [3] [4] [5] [6] [7] (Table 1 ) of the peptide sequence obtained from tryptic peptides of GM2 activator were present in pGAP2 and pGAP3. The protein sequence and the amino acid sequence derived from the cDNA were not 100 % identical. Two differences were noted: in the N-terminal peptide, the valine at position 25 is an isoleucine in the cDNA (amino acid 66); at position 14 of tryptic fragment 2, the alanine is a histidine in the cDNA (amino acid 117).
The N-terminus of GM2 activator was a phenylalanine (Table  1) according to the protein sequence analysis. The cDNA extends 5' beyond the phenylalanine, suggesting that GM2 activator exists as a precursor which is processed to its mature form. Methionine codons are present at positions 22 and 34 of the nucleotide sequence (Fig. 2) . The surrounding sequence of neither of these methionine codons matches the translation initiation consensus sequence [36] .
Four minor heterogeneities exist when comparing the placenta pGAP2 and pGAP3 sequences with the fibroblast pGAPI sequence ( Table 2 ). The nucleotide changes in three of the four positions (positions 76, 196, and 226) result in conservative alterations of the amino acid sequence and the change at the fourth position (nucleotide 603) gives a TAA stop codon rather than the TAG stop codon found in pGAPl. The two placental clones, pGAP2 and pGAP3, were identical in all of these positions.
Nucleotide sequence of pGM2A
The nucleotide sequence of pGM2A ( Fig. 1 ) revealed a striking difference when compared with the sequence ofGAP. Nucleotides 1-302 of pGM2A were almost identical with GAP. The sequences diverged dramatically, however, from position 303 to the 3' end of the clone. The pGM2A sequence has a stop codon at position 31 
125 TTA GTT 1TG GAG AAG GAG GTG GCT GGC CTC TGG ATC AAG ATC CCA TGC ACA GAC 178
CAC NTC TGT GAT GTG CTT GAC ATG TTA ATT 232 The nucleotide sequence of pGM2A and its derived amino acid sequence are shown. The plasmid containing the EcoRI insert and EcoRI/PstI subclones were used to obtain the complete sequence according to the strategy depicted. The primer 1 designation of the arrow indicates that primer 1 (below) was used as a sequencing primer. The sequence of nucleotides 1-59 was determined on only one strand since this sequence corresponds exactly to that of the previously published pGAPI [26] and pGAP2 and 3 (see below). The 266 bp PstI/EcoRI fragment was used as a GM2A-specific probe for Northern and Southern blot analyses. The primers used for PCR amplification are underlined. Primer 1 extends from nucleotides 200 to 220. The 3' PCR primer (primer 2) extends from nucleotides 607 to 626 and was synthesized as the reverse complement.
Amino acids in italicized bold type correspond to the protein sequence. The 5' and 3' EcoRI sites indicated on the diagram are linkers.
resulted from an artifact generated during subcloning or the construction of the library from which it was isolated. In order to verify the authenticity of pGM2A, PCR using total placental RNA as the initial template was performed as described in the Materials and methods section. The strategy for the amplification of pGM2A and pGAP was as follows: a primer derived from the common nucleotide sequence present in the 5' region of both pGM2A and pGAP (primer 1, Fig. 1 nucleotides 200-220; Fig.  2 nucleotides 346-366) was used as the 5' primer. The 3' primer was either specific for the 3' untranslated region of pGM2A (primer 2, Fig. 1 nucleotides 607-626) or specific for GAP (primer 3, Fig. 2 nucleotides 838-857) . Total RNA from placenta was used as templates to generate the first-strand cDNA for the PCR reaction. The expected fragments of 426 or 511 bp were obtained using the pGM2A-specific and GAP-specific 3' primers respectively. The PCR products were sequenced directly using primer 1. The nucleotide sequence of the 426 bp product was identical with that of pGM2A and the 511 bp fragment was identical with pGAP2. In a separate experiment, the same results were observed using fibroblast RNA as the initial template. Fig.  3 shows the sequences of the PCR products in the region of the transition from identical to divergent sequence. The point of transition is nucleotide 449 of GAP and 303 of pGM2A.
Amplification of an independent GM2A fragment It is conceivable that pGM2A plasmid DNA might have contaminated the reagents used for the PCR reactions described above and inadvertently served as the template to generate the 426 bp PCR product. To obtain a PCR product whose plasmid counterpart did not exist in our laboratory, an additional PCR amplification using placental RNA as the template was performed to generate a longer pGM2A cDNA. The pGM2A-specific primer (primer 2, Fig. 1 ) and a newly synthesized 5' primer corresponding to the 5' end of pGAP2 from nucleotides 16 to 36 (primer 4, Fig. 2) were used in the reaction. The selection of the 5' primer was based on an assumption that the nucleotide sequences at the 5' end of pGM2A and pGAP2 are identical. The 757 bp fragment produced by the PCR reaction was subcloned into Bluescript and sequenced. The nucleotide sequence of the fragment was 100 % identical with that of the region of pGM2A encompassed by the primers, with the additional 5' sequence corresponding to pGAP2, as expected (Fig. 4) . The The nucleotide sequence and the derived amino acid sequence of GAP are shown. experiment in conjunction with the PCR experiments described above strongly support the existence of at least two GM2 activator mRNAs in both fibroblasts and placenta.
Northern blot analysis of placental and fibroblast RNA In order to identify the mRNAs corresponding to the pGM2A and GAP cDNAs, Northern blots were prepared using placental and fibroblast poly(A)+ RNA (Fig. 5) . Identical amounts of each sample were electrophoresed in two sets on the same gel and transferred to a filter. The filter was cut in half to separate the two sets. One-half was hybridized with a pGM2A-specific fragment, the other with pGAP2 cDNA (see the Materials and methods section). The probes were labelled to a comparable specific radioactivity (approximately 108 c.p.m./,tg). Both pGM2A and pGAP2 (Fig. Sa) hybridized to one major mRNA species of approximately 2.3 kb in size. The intensity of the transcript that hybridized with the pGM2A-specific probe was greatly decreased compared with that identified with pGAP2 in both placenta and fibroblast. Hybridization of the same filters with a fl-actin probe (Fig. 5b) Fig. 2 ). A PCR product longer than the pGM2A cDNA was generated using primer 2 ( Fig. 1) and primer 4 which includes nucleotides 16-36 in Fig. 2 .
The fragment was sequenced to confirm its identity. [26] , by Fiirst et al. [37] , and from our peptide sequencing, the complete protein sequence of GM2 activator is present within the clones we described. It is probable that GM2 activator has a precursor form which is then processed to the mature protein. This suggestion is supported by the observation that the pGAP2 cDNA sequence has additional 5' coding sequence which extends beyond the N-terminal amino acid identified by protein sequencing. No definitive ATG initiation codon is present, although two methionine codons exist at positions 8 and 12 of the derived amino acid sequence of pGAP2. The nucleotide sequence surrounding neither of the ATG codons matches the consensus sequence characteristic of many translation initiation sites [36] . The mRNAs probably extend 3' as well, since there was no obvious polyadenylation signal, AATAAA, present in either GM2A or pGAP3.
Recently, more evidence has accumulated to show that saposins A-D, which are generated from the prepro-SAP-1 cDNA [38] [39] [40] [41] , correspond to three of the four classes of activator proteins (see the Introduction). Saposins A and C [39, 42] are the activators for the hydrolyses of GlcCer and GalCer; saposin B [39] is a non-specific activator which stimulates the hydrolysis of a number of glycolipids including GalCerSO4, GM 1 and GbOse3Cer, and saposin D [16] is the activator for the hydrolysis of sphingomyelin. Our results and that of Schr6der et al. [26] show that GAP and GM2A share no sequence homology with the cDNAs for the prepro-SAP-1 protein. Therefore GM2 activator is not a product of the prepro-SAP-l gene.
Our results also suggest that there are at least two species of mRNA which encode GM2 activator. Whether both GAP and GM2A can encode biologically active activator proteins requires investigation. It has been noticed that the highly purified GM2 activator isolated from human tissues always appears as a doublet band during electrophoresis [21, 43] . Whether the doublet protein is the product of the two species of mRNA is also unknown at this point. The pGAP and pGM2A cDNAs described in this report will provide the tools for expression studies to address these questions.
